Lee, Daniel J.
Hamghalam, Mohammad
Wang, Lily
Lin, Hui-Ming
Colak, Errol
Mamdani, Muhammad
Simpson, Amber L.
Lee, John M.
Article History
Received: 10 February 2025
Accepted: 1 April 2025
First Online: 27 April 2025
Declarations
:
: This study (LKS-CHART REB#16-371) was approved by the Unity Health Research Ethics Board. Due to retrospective nature of this study, informed consent was waived and approved by the Research Ethics Review Board.
: Not applicable (retrospective radiologic data).
: Daniel Lee and John Lee are on the advisory board for Sanofi Regeneron. Otherwise all others declare no relevant conflict of interest.